Enhanced Renal Toxicity of TotalBody Irradiation Combined with Radioimmunotherapy
2003
Total body irradiation (TBI) with and without additional
radioimmunotherapy (RIT) was examined for renal toxicity after
stem cell transplantation. Serum creatinine levels of 35 patients (15 female, 20
male, median age 40.5 years, range 17–60 years) after TBI alone
and of 23 patients (eight female, 15 male, median age 47, range
16–58 years) after TBI with additional RIT were determined
between 10/1997 and 11/1999. TBI was performed by external-beam
radiotherapy in six fractions over 3 days with renal doses of 12
Gy in the TBI-alone group and 6 Gy in the group with additional
RIT. The mean kidney dose due to the
188Re-radiolabeled antibody was
estimated to be 8.3 Gy (2.3–11.6 Gy). Within 12 months after treatment, creatinine levels
increased from 77 mmol/l (SD ± 11) to 89 mmol/l (SD ± 20) for
TBI alone and from 78 mmol/l (SD ± 13) to 144 mmol/l (SD ± 52)
for combined TBI and RIT. Despite a 50% reduction of the external-beam contribution
to the kidney dose, the application of approximately 10 GBq
188Re-labeled anti-CD66 monoclonal
antibody with a calculated renal dose of 8.3 Gy (range 2.3–11.5
Gy) led to renal toxicity, as reported previously. In the
absence of a positive dose-response relationship for the
188Re-labeled antibody, the
observation may be explained by an underestimation of the
biologically effective dose and the inaccuracy of the dose
determination at the glomerular level.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI